ArticleNeurology and therapy2022

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.

Maria Petracca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.